RGRX
$0.44
Regenerx Biopharmaceuticals
$.02
4.46%
RGRX
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Nov 13
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when RGRX reports earnings?
Beat
Meet
Miss

Where is RGRX's stock price going from here?
Up
Flat
Down
Stock chart of RGRX
Analysts
Summary of analysts' recommendations for RGRX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
RegeneRx is a biopharmaceutical company that holds over fifty world-wide patents and patent applications related to dermal, ocular, and internal wounds and tissue repair, including the treatment and prevention of cardiac and neurological injuries.